RDY 398 (Lansoprazole delayed release 15 mg)
Pill imprint RDY 398 has been identified as Lansoprazole delayed release 15 mg.
Lansoprazole is used in the treatment of gerd; barrett's esophagus; stomach ulcer; erosive esophagitis; nsaid-induced ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RDY 398 (Lansoprazole delayed release 15 mg)
Lansoprazole delayed release
- Imprint:
-
RDY
398 - Strength:
- 15 mg
- Color:
- Pink / Green
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- 55111-0398
- Inactive Ingredients:
- ammonia
hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
magnesium carbonate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
polysorbate 80
propylene glycol
shellac
corn starch
sucrose
raw sugar
titanium dioxide
magnesium silicate
gelatin
ferric oxide red
ferric oxide yellow
FD&C Blue No. 2
sodium lauryl sulfate
More resources
Lansoprazole delayed release is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
